ArticleSurgical neurology international2026
Nationwide trends and outcomes of transsphenoidal pituitary surgery: A 15-year analysis from the public healthcare system.
Article in Surgical neurology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Transsphenoidal pituitary surgery is the standard approach for sellar lesions worldwide. However, little is known about its epidemiology, outcomes, and economic burden in low- and middle-income countries. We aimed to analyze nationwide trends of transsphenoidal pituitary surgery in Brazil, using 15 years of data from the public healthcare system. Methods: This was a retrospective, population-based study including patients who underwent transsphenoidal pituitary surgery between 2010 and 2024 in Brazil's Unified Health System (SUS), the public health system. Data were from the national hospital database, covering surgical volume, mortality, length of stay (LOS), and costs. Results: A total of 8,934 surgeries were performed nationwide over 15 years. The Southeast region was responsible for 65% of the surgeries. Surgical volume increased significantly in the Midwest. The median LOS was 11.4 ± 1.2 days, with a progressive decline over time. The average SUS reimbursement was US$878 ± 97 per hospitalization, showing a significant upward trend from 2010 to 2024, with similar values across regions. The overall in-hospital mortality rate was 1.4%. Conclusion: This is the first nationwide study in Latin America to evaluate transsphenoidal pituitary surgeries within a public health system. The findings reveal pronounced regional disparities, with surgical care highly concentrated in the Southeast, while access remains limited in the North and Northeast. Despite demonstrating that the procedure is safe, with low and stable mortality rates, the reimbursement provided by the SUS is substantially lower than international costs, even in the context of longer hospital stays.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.